ANACOR PHARMACEUTICALS INC's ticker is ANAC and the CUSIP is 032420101. A total of 142 filers reported holding ANACOR PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 2.00 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $57,079,000 | -52.7% | 1,067,892 | 0.0% | 31.25% | -24.7% |
| Q4 2015 | $120,640,000 | -4.0% | 1,067,892 | 0.0% | 41.48% | -0.6% |
| Q3 2015 | $125,702,000 | +52.0% | 1,067,892 | 0.0% | 41.75% | +44.4% |
| Q2 2015 | $82,687,000 | +33.8% | 1,067,892 | 0.0% | 28.91% | +12.2% |
| Q1 2015 | $61,778,000 | +79.4% | 1,067,892 | 0.0% | 25.76% | +68.6% |
| Q4 2014 | $34,440,000 | +31.8% | 1,067,892 | 0.0% | 15.28% | +16.4% |
| Q3 2014 | $26,131,000 | +38.0% | 1,067,892 | 0.0% | 13.12% | +78.4% |
| Q2 2014 | $18,934,000 | -11.4% | 1,067,892 | 0.0% | 7.36% | -11.8% |
| Q1 2014 | $21,369,000 | -68.7% | 1,067,892 | -73.7% | 8.34% | -76.1% |
| Q4 2013 | $68,259,000 | +14.3% | 4,067,892 | -27.6% | 34.97% | -4.5% |
| Q3 2013 | $59,700,000 | +90.0% | 5,621,423 | 0.0% | 36.62% | +43.5% |
| Q2 2013 | $31,424,000 | – | 5,621,423 | – | 25.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 1,067,892 | $125,702,000 | 41.75% |
| VHCP Management, LLC | 1,178,474 | $138,718,000 | 35.56% |
| Palo Alto Investors LP | 2,579,154 | $303,592,000 | 14.60% |
| Baker Brothers Advisors | 4,135,412 | $486,779,000 | 4.50% |
| APIS CAPITAL ADVISORS, LLC | 23,000 | $2,708,000 | 3.75% |
| EMORY UNIVERSITY | 11,096 | $1,306,000 | 3.64% |
| Atika Capital Management LLC | 61,000 | $7,180,000 | 3.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 488,912 | $57,550,000 | 2.78% |
| Segantii Capital Management Ltd | 100,000 | $11,134,000 | 2.55% |
| NEXT CENTURY GROWTH INVESTORS LLC | 428,835 | $50,478,000 | 2.10% |